Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure
- PMID:27420737
- DOI: 10.1021/acs.jmedchem.6b00564
Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like Structure
Abstract
Dimeric/oligomeric states of G-protein coupled receptors have been difficult to target. We report here bivalent ligands consisting of two identical oxytocin-mimetics that induce a three order magnitude boost in G-protein signaling of oxytocin receptors (OTRs) in vitro and a 100- and 40-fold gain in potency in vivo in the social behavior of mice and zebrafish. Through receptor mutagenesis and interference experiments with synthetic peptides mimicking transmembrane helices (TMH), we show that such superpotent behavior follows from the binding of the bivalent ligands to dimeric receptors based on a TMH1-TMH2 interface. Moreover, in this arrangement, only the analogues with a well-defined spacer length (∼25 Å) precisely fit inside a channel-like passage between the two protomers of the dimer. The newly discovered oxytocin bivalent ligands represent a powerful tool for targeting dimeric OTR in neurodevelopmental and psychiatric disorders and, in general, provide a framework to untangle specific arrangements of G-protein coupled receptor dimers.
Similar articles
- Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors.Busnelli M, Bulgheroni E, Manning M, Kleinau G, Chini B.Busnelli M, et al.J Pharmacol Exp Ther. 2013 Aug;346(2):318-27. doi: 10.1124/jpet.113.202994. Epub 2013 May 30.J Pharmacol Exp Ther. 2013.PMID:23723434Free PMC article.
- Oxytocin receptors: ligand binding, signalling and cholesterol dependence.Gimpl G, Reitz J, Brauer S, Trossen C.Gimpl G, et al.Prog Brain Res. 2008;170:193-204. doi: 10.1016/S0079-6123(08)00417-2.Prog Brain Res. 2008.PMID:18655883Review.
- Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers.Berque-Bestel I, Lezoualc'h F, Jockers R.Berque-Bestel I, et al.Curr Drug Discov Technol. 2008 Dec;5(4):312-8. doi: 10.2174/157016308786733591.Curr Drug Discov Technol. 2008.PMID:19075611Review.
- Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.Muttenthaler M, Andersson Å, Vetter I, Menon R, Busnelli M, Ragnarsson L, Bergmayr C, Arrowsmith S, Deuis JR, Chiu HS, Palpant NJ, O'Brien M, Smith TJ, Wray S, Neumann ID, Gruber CW, Lewis RJ, Alewood PF.Muttenthaler M, et al.Sci Signal. 2017 Dec 5;10(508):eaan3398. doi: 10.1126/scisignal.aan3398.Sci Signal. 2017.PMID:29208680Free PMC article.
- Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer.Devost D, Zingg HH.Devost D, et al.J Mol Endocrinol. 2003 Dec;31(3):461-71. doi: 10.1677/jme.0.0310461.J Mol Endocrinol. 2003.PMID:14664707
Cited by
- The oxytocin receptor represents a key hub in the GPCR heteroreceptor network: potential relevance for brain and behavior.Borroto-Escuela DO, Cuesta-Marti C, Lopez-Salas A, Chruścicka-Smaga B, Crespo-Ramírez M, Tesoro-Cruz E, Palacios-Lagunas DA, Perez de la Mora M, Schellekens H, Fuxe K.Borroto-Escuela DO, et al.Front Mol Neurosci. 2022 Dec 8;15:1055344. doi: 10.3389/fnmol.2022.1055344. eCollection 2022.Front Mol Neurosci. 2022.PMID:36618821Free PMC article.Review.
- Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.Pulido D, Casadó-Anguera V, Pérez-Benito L, Moreno E, Cordomí A, López L, Cortés A, Ferré S, Pardo L, Casadó V, Royo M.Pulido D, et al.J Med Chem. 2018 Oct 25;61(20):9335-9346. doi: 10.1021/acs.jmedchem.8b01249. Epub 2018 Oct 11.J Med Chem. 2018.PMID:30257092Free PMC article.
- Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.Ericson MD, Lensing CJ, Fleming KA, Schlasner KN, Doering SR, Haskell-Luevano C.Ericson MD, et al.Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2414-2435. doi: 10.1016/j.bbadis.2017.03.020. Epub 2017 Mar 29.Biochim Biophys Acta Mol Basis Dis. 2017.PMID:28363699Free PMC article.Review.
- Delineation of molecular determinants for FR900359 inhibition of Gq/11 unlocks inhibition of Gαs.Boesgaard MW, Harpsøe K, Malmberg M, Underwood CR, Inoue A, Mathiesen JM, König GM, Kostenis E, Gloriam DE, Bräuner-Osborne H.Boesgaard MW, et al.J Biol Chem. 2020 Oct 2;295(40):13850-13861. doi: 10.1074/jbc.RA120.013002. Epub 2020 Aug 4.J Biol Chem. 2020.PMID:32753482Free PMC article.
- Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.Song Z, Albers HE.Song Z, et al.Front Neuroendocrinol. 2018 Oct;51:14-24. doi: 10.1016/j.yfrne.2017.10.004. Epub 2017 Oct 18.Front Neuroendocrinol. 2018.PMID:29054552Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases